Cardax, Inc. (CDXI)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.0039 (-97.50%)
At close: Sep 24, 2025
Cardax Market Cap
Cardax has a market cap or net worth of $83 as of October 22, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
83.00
Enterprise Value
n/a
Revenue
500.71K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 10, 2014, Cardax's market cap has decreased from 191.71M to 83.00, a decrease of -100.00%. That is a compound annual growth rate of -71.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2025 | 83.00 | - |
| Dec 31, 2024 | 83.00 | -49.70% |
| Dec 27, 2022 | 165.00 | -99.96% |
| Dec 30, 2021 | 412.79K | -68.27% |
| Dec 31, 2020 | 1.30M | -81.33% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 804.99M |
| Elite Pharmaceuticals | 644.08M |
| Glass House Brands | 624.73M |
| Silence Therapeutics | 349.53M |
| Nika Pharmaceuticals | 335.28M |
| CytoDyn | 327.41M |
| Northwest Biotherapeutics | 324.50M |
| American Oncology Network | 289.95M |